Elucigene TRP-F Kits
Venous thrombosis causes an estimated 50,000 deaths per year in the US and has an incidence of 1 per 1000 annually. There are many reported risk factors including a genetic element that can contribute to thrombosis. Cardiovascular disease is a leading cause of death for both men and women in most racial ethnic groups.
The Elucigene TRP-F (Thrombosis Risk Panel-Fluorescent) product is a recently developed kit that provides laboratories with a simple and accurate means of routinely testing for the three most relevant mutations implicated in the risk of developing venous thromboembolism. The Elucigene TRP-F is provided as a single mix that only requires the addition of patient DNA for rapid analysis on the Applied Biosystems 3*** series Genetic Analyzers.
The factor V Leiden (R506Q) mutation is the most common inherited form of thrombophilia, but the Prothrombin 20210A (factor II) and MTHFR (methylenetetrahyrofolate reductase) C677T also contribute toward increased risk.
This product is not approved by the FDA and is not available for sale in the US
| Description | Quantity | Catalogue |
|---|---|---|
| The Elucigene TRP-F (Thrombosis Risk Panel-Fluorescent): is a recently developed kit that provides laboratories with a simple and accurate means of routinely testing for the three most relevant mutations implicated in the risk of developing venous thromboembolism. Elucigene TRP-F is provided as a single mix that only requires the addition of patient DNA for rapid analysis on the Applied Biosystems 3*** series Genetic Analyzers. |
50 | THF03B2 |
NOTE: The Elucigene TRP-F kit is also offered as a gel based assay (TH003B2) for analysis of factor V Leiden (R506Q), Prothrombin 20210A (factor II) and MTHFR (methylenetetrahyrofolate reductase) C677T.
| Cat # | Product | Kit Size | Instructions for Use |
|---|---|---|---|
| THF03B2 | Elucigene TRP-F | 50 tests | EN |
GeneMapper analysis files & settings:
| GeneMapper 3.7 and above |
| GeneMapper settings |
| Cat # | Product | Kit Size | MSDS |
|---|---|---|---|
| THF03B2 | Elucigene TRP-F | 50 tests | EN |
TRP-F kits comply with the IVDD EC Directive 98/79/EC, carry the CE mark and are manufactured within quality systems accredited to ISO9001:2008 and ISO13485:2003. Full technical support is provided to purchasers of kits to ensure acceptable performance and customer satisfaction.
Please note: Licences for the in vitro diagnostic analysis of gene mutations detected by these reagents may be required and are the responsibility of the reagent purchaser.
This product is not approved by the FDA and is not available for sale in the US
For additional availability in other countries please contact your local sales rep or distributor.
For information on our Elucigene TRP-F product please download our brochures:
A4 brochure: Click to Download